George Drusano is director of the Institute for Therapeutic Innovation at the University of Florida, whose mission is to improve the therapy for serious infectious diseases.
After graduating magna cum laude from the honours programme at Boston College, George graduated cum laude from the University of Maryland School of Medicine in Baltimore. He completed his medical internship and residency at the University of Maryland Hospital, where he was also Chief Medical Resident and a Fellow in Medicines in Infectious Diseases.
George was a Professor at the University of Maryland, Head of the Division of Clinical Pharmacology at Albany Medical College and ran the Infectious Diseases group at Ordway Research Institute prior to joining the University of Florida.
George is the author of over 320 peer-reviewed publications. He was also editor of the section of pharmacology and experimental therapeutics for Antimicrobial Agents and Chemotherapy for 10 years and worked as an editor for mBio.
George is a Fellow of the Infectious Diseases Society of America. On the national level, he was a member of the Interscience Conference on Antimicrobial Agents and Chemotherapeutics (ICAAC) Program Committee and the Infectious Diseases Society of America Program Committee.
He has served on multiple National Institute of Allergy and Infectious Diseases (NIAID) Review Groups; and as an ad hoc member of the NIAID Council on two occasions to support issues regarding emergence of bacterial resistance. George is also a consultant to NIAID and the Centers for Disease Control and Prevention (CDC) on Biodefense issues.
George chaired the Gordon Research Conference on New Antimicrobial Discovery and Development in 2010. He has won several awards, including being named Distinguished Investigator of the Year, 2003, by the American College of Clinical Pharmacology. In 2015 he was awarded the Paul Ehrlich Magic Bullet Award.